[1] GERDTS E, REGITZ-ZAGROSEK V. Sex differences in cardiometabolic disorders [J]. Nat Med, 2019, 25 (11) : 1657-1666.
[2] FABBRI E, AN Y, ZOLI M, et al. Association between accelerated multimorbidity and age-related cognitive decline in older Baltimore longitudinal study of aging participants without dementia [J]. J Am Geriatr Soc, 2016, 64 (5) : 965-972.
[3] CALDERÓN-LARRAÑAGA A, VETRANO D L, ONDER G, et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization [J]. J Gerontol A Biol Sci Med Sci, 2017, 72 (10) : 1417-1423.
[4] MARENGONI A, ANGLEMAN S, MELIS R, et al. Aging with multimorbidity: a systematic review of the literature [J]. Ageing Res Rev, 2011, 10 (4) : 430-439.
[5] KOYANAGI A, LARA E, STUBBS B, et al. Chronic physical conditions, multimorbidity, and mild cognitive impairment in low-and middle-income countries [J]. J Am Geriatr Soc, 2018, 66 (4) : 721-727.
[6] VASSILAKI M, AAKRE J A, CHA R H, et al. Multimorbidity and risk of mild cognitive impairment [J]. J Am Geriatr Soc, 2015, 63 (9) : 1783-1790.
[7] CALVIN C M, CONROY M C, MOORE S F, et al. Association of multimorbidity, disease clusters, and modification by genetic factors with risk of dementia [J]. JAMA Netw Open, 2022, 5 (9) : e2232124.
[8] AARTS S, VAN DEN AKKER M, TAN F E, et al. Influence of multimorbidity on cognition in a normal aging population: a 12-year follow-up in the Maastricht Aging Study [J]. Int J Geriatr Psychiatry, 2011, 26 (10) : 1046-1053.
[9] JACOB L, HARO J M, KOYANAGI A. Physical multimorbidity and subjective cognitive complaints among adults in the United Kingdom: a cross-sectional community-based study [J]. Sci Rep, 2019, 9 (1) : 12417.
[10] ELDHOLM R S, PERSSON K, BARCA M L, et al. Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics [J]. BMC Geriatr, 2018, 18 (1) : 120.
[11] BEN HASSEN C, FAYOSSE A, LANDRÉ B, et al. Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in WhitehallⅡ prospective cohort study [J]. BMJ, 2022, 376: e068005.
[12] DOVE A, GUO J, MARSEGLIA A, et al. Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry [J]. Eur Heart J, 2023, 44 (7) : 573-582.
[13] SHANG X W, ZHANG X L, HUANG Y, et al. Association of a wide range of individual chronic diseases and their multimorbidity with brain volumes in the UK Biobank: a cross-sectional study [J]. EClinicalMedicine, 2022, 47: 101413.
[14] SHANG X W, ZHU Z T, ZHANG X L, et al. Association of a wide range of chronic diseases and apolipoprotein E4 genotype with subsequent risk of dementia in community-dwelling adults: a retrospective cohort study [J]. EClinicalMedicine, 2022, 45: 101335.
[15] 周思静, 罗邦安, 曹慧, 等. ≥65岁居民老年痴呆流行病学特征及其与慢性病共病的相关性研究 [J]. 中国全科医学, 2023, 26 (29) : 3616-3621.
[16] SONG X W, MITNITSKI A, ROCKWOOD K. Nontraditional risk factors combine to predict Alzheimer disease and dementia [J]. Neurology, 2011, 77 (3) : 227-234.
[17] CHARLSON M E, POMPEI P, ALES K L, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation [J]. J Chronic Dis, 1987, 40 (5) : 373-383.
[18] WASTESSON J W, MORIN L, TAN E C K, et al. An update on the clinical consequences of polypharmacy in older adults: a narrative review [J]. Expert Opin Drug Saf, 2018, 17 (12) : 1185-1196.
[19] NAFTI M, SIROIS C, KRÖGER E, et al. Is benzodiazepine use associated with the risk of dementia and cognitive impairment-not dementia in older persons? the Canadian study of health and aging [J]. Ann Pharmacother, 2020, 54 (3) : 219-225.
[20] BOYD C M, DARER J, BOULT C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance [J]. JAMA, 2005, 294 (6) : 716-724.
[21] KALISCH ELLETT L M, PRATT N L, RAMSAY E N, et al. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia [J]. J Am Geriatr Soc, 2014, 62 (10) : 1916-1922.
[22] WANG Z D, MARSEGLIA A, SHANG Y, et al. Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: a population-based longitudinal study [J]. Alzheimers Dement, 2020, 16 (2) : 316-325.
[23] SAKAKIBARA B M, OBEMBE A O, ENG J J. The prevalence of cardiometabolic multimorbidity and its association with physical activity, diet, and stress in Canada: evidence from a population-based cross-sectional study [J]. BMC Public Health, 2019, 19 (1) : 1361.
[24] FREISLING H, VIALLON V, LENNON H, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study [J]. BMC Med, 2020, 18 (1) : 5.
[25] GRANDE G, MARENGONI A, VETRANO D L, et al. Multimorbidity burden and dementia risk in older adults: the role of inflammation and genetics [J]. Alzheimers Dement, 2021, 17 (5) : 768-776.
[26] BARULLI D, STERN Y. Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve [J]. Trends Cogn Sci, 2013, 17 (10) : 502-509.
[27] NYBERG L, LÖVDÉN M, RIKLUND K, et al. Memory aging and brain maintenance [J]. Trends Cogn Sci, 2012, 16 (5) : 292-305.
[28] JIN Y Z, LIANG J, HONG C L, et al. Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort study [J]. Lancet Healthy Longev, 2023, 4 (6) : e265-273.
[29] RAMOS-VERA C, SAINTILA J, O'DIANA A G, et al. Identifying latent comorbidity patterns in adults with perceived cognitive impairment: network findings from the behavioral risk factor surveillance system [J]. Front Public Health, 2022, 10: 981944.
[30] KHONDOKER M, MACGREGOR A, BACHMANN M O, et al. Multimorbidity pattern and risk of dementia in later life: an 11-year follow-up study using a large community cohort and linked electronic health records [J]. J Epidemiol Community Health, 2023, 77 (5) : 285-292.
[31] LIVINGSTON G, HUNTLEY J, SOMMERLAD A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission [J]. Lancet, 2020, 396 (10248) : 413-446.
[32] DOVE A, MARSEGLIA A, SHANG Y, et al. Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression [J]. Alzheimers Dement, 2022.
[33] HSIEH P I, CHEN Y C, CHEN T F, et al. Multimorbid patterns and cognitive performance in the presence of informative dropout among community-dwelling Taiwanese older adults [J]. Innov Aging, 2023, 7 (2) : igad012.
[34] SHABIR O, MOLL T A, MATUSZYK M M, et al. Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia [J]. Mech Ageing Dev, 2020, 192: 111361.
[35] PEERS C, DALLAS M L, BOYCOTT H E, et al. Hypoxia and neurodegeneration [J]. Ann N Y Acad Sci, 2009, 1177: 169-177.
[36] QIU C X, FRATIGLIONI L. A major role for cardiovascular burden in age-related cognitive decline [J]. Nat Rev Cardiol, 2015, 12 (5) : 267-277.
[37] BIESSELS G J, DESPA F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications [J]. Nat Rev Endocrinol, 2018, 14 (10) : 591-604.
[38] PASE M P, GRIMA N A, STOUGH C K, et al. Cardiovascular disease risk and cerebral blood flow velocity [J]. Stroke, 2012, 43 (10) : 2803-2805.
[39] DOTTI C G, STROOPER B D. Alzheimer's dementia by circulation disorders: when trees hide the forest [J]. Nat Cell Biol, 2009, 11 (2) : 114-116.
[40] ZUO W H, WU J H. The interaction and pathogenesis between cognitive impairment and common cardiovascular diseases in the elderly [J]. Ther Adv Chronic Dis, 2022, 13: 20406223211063020.
[41] DONATH M Y, MEIER D T, BÖNI-SCHNETZLER M. Inflammation in the pathophysiology and therapy of cardiometabolic disease [J]. Endocr Rev, 2019, 40 (4) : 1080-1091.
[42] HENEKA M T, CARSON M J, EL KHOURY J, et al. Neuroinflammation in Alzheimer's disease [J]. Lancet Neurol, 2015, 14 (4) : 388-405.
[43] NGANDU T, LEHTISALO J, SOLOMON A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER) : a randomised controlled trial [J]. Lancet, 2015, 385 (9984) : 2255-2263.
[44] BARLOW J H, BANCROFT G V, TURNER A P. Self-management training for people with chronic disease: a shared learning experience [J]. J Health Psychol, 2005, 10 (6) : 863-872.
[45] PAZAN F, PETROVIC M, CHERUBINI A, et al. A systematic review of the current evidence from randomised controlled trials on the impact of medication optimisation or pharmacological interventions on quantitative measures of cognitive function in geriatric patients [J]. Drugs Aging, 2022, 39 (11) : 863-874.
